NEW YORK (GenomeWeb) – Somalogic said today it has licensed GNS Healthcare's REFS (Reverse Engineering & Forward Simulation) causal machine learning technology.

Somalogic said it will use the REFS technology to analyze protein datasets generated by its SomaScan proteomic platform to convert them into information that can be used in meaningful ways to manage health at the individual and population levels.

Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.